Skip to content

The effects of Wadaiko program for community-dwelling older adults

The effects of Wadaiko program for community-dwelling older adults - Wadaiko trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1090220147
Enrollment
80
Registered
2013-11-18
Start date
2014-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

older adults

Interventions

Intervention type:BEHAVIOUR Name of intervention:Wadaiko program Dose form / Japanese Medical Device Nomenclature:NOT APPLICABLE Route of administration / Site of application:NOT APPLICABLE Dose per a

Sponsors

Hidenori ARAI
Lead Sponsor
Minoru YAMADA
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Community-dwelling older adults aged 65 and older at risk of depression

Exclusion criteria

Exclusion criteria: cardiac disorder, pulmonary disorder, severe musculoskeletal disorder, stroke, parkinsons' disease

Design outcomes

Primary

MeasureTime frame
mood state

Secondary

MeasureTime frame
Mental state Physical function

Countries

Japan

Contacts

Public ContactHidenori ARAI

Kyoto University Graduate school of Medicine

harai@kuhp.kyoto-u.ac.jp+81-75-751-3944

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026